| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |